InvestorsHub Logo
Followers 3
Posts 213
Boards Moderated 0
Alias Born 01/03/2018

Re: None

Sunday, 04/28/2019 5:49:37 PM

Sunday, April 28, 2019 5:49:37 PM

Post# of 50157
Agree BK or heavy dilution is majorly in play. Hoping for some sort of revenue sharing deal. I think we need to see some good news on Medac, to stay alive. That is the only catalyst.

The literature says the dCTh offering is helping patients, but distribution has been terrible, only Medac can help with that. If distribution is better, and we survive BK, I assume we will cut a revenue sharing deal for South American potential revenue.


Only reason I have stayed long is to see if Medac was able to increase distribution.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News